Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1980 Oct;133(4):297–303.

Hip Fracture, Skeletal Fragility, Osteoporosis and Hormonal Deprivation in Elderly Women

Elmer E Specht 1
PMCID: PMC1272306  PMID: 6287739

Abstract

Fractures of the hip have been shown to have a significant personal and societal impact in Western countries; this impact is largely borne by elderly women, and represents a substantial health care commitment in modern society. For many people a fracture of the proximal end of the femur represents a preterminal event of considerable cost, both in economic loss and psychosocial well-being. These fractures are generally recognized as a clinical complication of osteoporosis, and are one index of general skeletal fragility which is also manifested in fractures of the vertebrate and of the distal radius (Colles fracture).

There is increasing evidence that hormonal deprivation in elderly women is directly related to loss of skeletal integrity and consequent fragility. There is also increasing evidence that hormonal substitution is effective in preventing this structural loss and fragility. Unfortunately, a therapeutic dilemma has arisen in that the preparation that seems to give optimal protection, conjugated estrogens, has also been reported to cause an increased incidence of endometrial carcinoma. The search for a preparation or dosage regimen of estrogens which simultaneously prevents skeletal atrophy and fragility and avoids the increased risk of malignancy must be a long-term goal.

Full text

PDF
297

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken J. M., Hart D. M., Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J. 1973 Sep 8;3(5879):515–518. doi: 10.1136/bmj.3.5879.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alhava E. M. Diseases contributing to fragility of bone in patients with hip fractures. Ann Clin Res. 1974 Aug;6(4):246–252. [PubMed] [Google Scholar]
  3. Alhava E. M., Karjalainen P. Mineral content and density of the forearm bones measured by Am-241 gamma ray attenuation method in 80 patients with osteoporotic hip fractures. Ann Clin Res. 1973 Aug;5(4):244–247. [PubMed] [Google Scholar]
  4. Antunes C. M., Strolley P. D., Rosenshein N. B., Davies J. L., Tonascia J. A., Brown C., Burnett L., Rutledge A., Pokempner M., Garcia R. Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med. 1979 Jan 4;300(1):9–13. doi: 10.1056/NEJM197901043000103. [DOI] [PubMed] [Google Scholar]
  5. Barnes R., Brown J. T., Garden R. S., Nicoll E. A. Subcapital fractures of the femur. A prospective review. J Bone Joint Surg Br. 1976 Feb;58(1):2–24. doi: 10.1302/0301-620X.58B1.1270491. [DOI] [PubMed] [Google Scholar]
  6. Beals R. K. Survival following hip fracture. Long follow-up of 607 patients. J Chronic Dis. 1972 Apr;25(4):235–244. doi: 10.1016/0021-9681(72)90134-8. [DOI] [PubMed] [Google Scholar]
  7. Byrd B. F., Jr, Burch J. C., Vaughn W. K. The impact of long term estrogen support after hysterectomy. A report of 1016 cases. Ann Surg. 1977 May;185(5):574–580. doi: 10.1097/00000658-197705000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dalén N., Lamke B., Wallgren A. Bone-mineral losses in oophorectomized women. J Bone Joint Surg Am. 1974 Sep;56(6):1235–1238. [PubMed] [Google Scholar]
  9. Davis M. E., Lanzl L. H., Strandjord N. M. Estrogens and the aging process. The detection, prevention, and retardation of osteoporosis. JAMA. 1966 Apr 18;196(3):219–224. [PubMed] [Google Scholar]
  10. Dequeker J. V. Pattern of development and loss of bone with age. Lancet. 1970 Feb 14;1(7642):359–360. doi: 10.1016/s0140-6736(70)90736-1. [DOI] [PubMed] [Google Scholar]
  11. Foss M. V., Byers P. D. Bone density, osteoarthrosis of the hip, and fracture of the upper end of the femur. Ann Rheum Dis. 1972 Jul;31(4):259–264. doi: 10.1136/ard.31.4.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gordan G. S., Picchi J., Roof B. S. Antifracture efficacy of long-term estrogens for osteoporosis. Trans Assoc Am Physicians. 1973;86:326–332. [PubMed] [Google Scholar]
  13. HENNEMAN P. H., WALLACH S. A review of the prolonged use of estrogens and androgens in postmenopausal and senile osteoporosis. AMA Arch Intern Med. 1957 Nov;100(5):715–723. doi: 10.1001/archinte.1957.00260110031005. [DOI] [PubMed] [Google Scholar]
  14. Horsman A., Gallagher J. C., Simpson M., Nordin B. E. Prospective trial of oestrogen and calcium in postmenopausal women. Br Med J. 1977 Sep 24;2(6090):789–792. doi: 10.1136/bmj.2.6090.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Horwitz R. I., Feinstein A. R. Alternative analytic methods for case-control studies of estrogens and endometrial cancer. N Engl J Med. 1978 Nov 16;299(20):1089–1094. doi: 10.1056/NEJM197811162992001. [DOI] [PubMed] [Google Scholar]
  16. Hutchinson T. A., Polansky S. M., Feinstein A. R. Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet. 1979 Oct 6;2(8145):705–709. doi: 10.1016/s0140-6736(79)90640-8. [DOI] [PubMed] [Google Scholar]
  17. Iskrant A. P., Smith R. W., Jr Osteoporosis in women 45 years and over related to subsequent fractures. Public Health Rep. 1969 Jan;84(1):33–38. [PMC free article] [PubMed] [Google Scholar]
  18. Jick H., Watkins R. N., Hunter J. R., Dinan B. J., Madsen S., Rothman K. J., Walker A. M. Replacement estrogens and endometrial cancer. N Engl J Med. 1979 Feb 1;300(5):218–222. doi: 10.1056/NEJM197902013000502. [DOI] [PubMed] [Google Scholar]
  19. Khairi M. R., Cronin J. H., Robb J. A., Smith D. M., Johnston C. C., Jr Femoral trabecular-pattern index and bone mineral content measurement by photon absorption in senile osteoporosis. J Bone Joint Surg Am. 1976 Mar;58(2):221–226. [PubMed] [Google Scholar]
  20. Kohn P., Zekert F., Vormittag E., Grabner H. Risks of operation in patients over 80. Geriatrics. 1973 Nov;28(11):100–105. [PubMed] [Google Scholar]
  21. Lindsay R., Hart D. M., Aitken J. M., MacDonald E. B., Anderson J. B., Clarke A. C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1976 May 15;1(7968):1038–1041. doi: 10.1016/s0140-6736(76)92217-0. [DOI] [PubMed] [Google Scholar]
  22. Lindsay R., Hart D. M., MacLean A., Clark A. C., Kraszewski A., Garwood J. Bone response to termination of oestrogen treatment. Lancet. 1978 Jun 24;1(8078):1325–1327. doi: 10.1016/s0140-6736(78)92402-9. [DOI] [PubMed] [Google Scholar]
  23. Lindsay R., Hart D. M., Purdie D., Ferguson M. M., Clark A. S., Kraszewski A. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clin Sci Mol Med. 1978 Feb;54(2):193–195. doi: 10.1042/cs0540193. [DOI] [PubMed] [Google Scholar]
  24. MIKKELSEN O. A., LANGHOLM O. LIFE EXPECTANCY AFTER HIP FRACTURES IN THE AGED. Acta Chir Scand. 1964 Jan-Feb;127:46–56. [PubMed] [Google Scholar]
  25. Meema H. E., Meema S. Involutional (physiologic) bone loss in women and the feasibility of preventing structural failure. J Am Geriatr Soc. 1974 Oct;22(10):443–452. doi: 10.1111/j.1532-5415.1974.tb04812.x. [DOI] [PubMed] [Google Scholar]
  26. Meema H. E., Meema S. Prevention of postmenopausal osteoporosis by hormone treatment of the menopause. Can Med Assoc J. 1968 Aug 10;99(6):248–251. [PMC free article] [PubMed] [Google Scholar]
  27. Meema S., Bunker M. L., Meema H. E. Preventive effect of estrogen on postmenopausal bone loss. Arch Intern Med. 1975 Nov;135(11):1436–1440. [PubMed] [Google Scholar]
  28. Newton-John H. F., Morgan D. B. The loss of bone with age, osteoporosis, and fractures. Clin Orthop Relat Res. 1970;71:229–252. [PubMed] [Google Scholar]
  29. Nilsson B. E. Spinal osteoporosis and femoral neck fracture. Clin Orthop Relat Res. 1970 Jan-Feb;68:93–95. [PubMed] [Google Scholar]
  30. Nordin B. E., Gallagher J. C., Aaron J. E., Horsman A. Post-menopausal osteopenia and osteoporosis. Front Horm Res. 1975;3:131–149. doi: 10.1159/000398272. [DOI] [PubMed] [Google Scholar]
  31. Nordin B. E., MacGregor J., Smith D. A. The incidence of osteoporosis in normal women: its relation to age and the menopause. Q J Med. 1966 Jan;35(137):25–38. [PubMed] [Google Scholar]
  32. Recker R. R., Saville P. D., Heaney R. P. Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med. 1977 Dec;87(6):649–655. doi: 10.7326/0003-4819-87-6-649. [DOI] [PubMed] [Google Scholar]
  33. Riggs B. L., Hodgson S. F., Hoffman D. L., Kelly P. J., Johnson K. A., Taves D. Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence. JAMA. 1980 Feb 1;243(5):446–449. [PubMed] [Google Scholar]
  34. STEVENS J., FREEMAN P. A., NORDIN B. E., BARNETT E. The incidence of osteoporosis in patients with femoral neck fracture. J Bone Joint Surg Br. 1962 Aug;44-B:520–527. doi: 10.1302/0301-620X.44B3.520. [DOI] [PubMed] [Google Scholar]
  35. Singh M., Nagrath A. R., Maini P. S. Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg Am. 1970 Apr;52(3):457–467. [PubMed] [Google Scholar]
  36. Smith D. C., Prentice R., Thompson D. J., Herrmann W. L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975 Dec 4;293(23):1164–1167. doi: 10.1056/NEJM197512042932302. [DOI] [PubMed] [Google Scholar]
  37. Sweet M. B., Mendelow A., Kotler M. N., Graham W. D. Fractured neck of femur. Associated morbidity and mortality. S Afr J Surg. 1967 Jan-Mar;5(1):57–64. [PubMed] [Google Scholar]
  38. VOSE G. P., STOVER B. J., MACK P. B. Quantitative bone strength measurements in senile osteoporosis. J Gerontol. 1961 Apr;16:120–124. doi: 10.1093/geronj/16.2.120. [DOI] [PubMed] [Google Scholar]
  39. Wylie C. M. Hospitalization for fractures and bone loss in adults. Why do we regard these phenomena as dull? Public Health Rep. 1977 Jan-Feb;92(1):33–38. [PMC free article] [PubMed] [Google Scholar]
  40. Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975 Dec 4;293(23):1167–1170. doi: 10.1056/NEJM197512042932303. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES